Caffeine Recruiting Phase 4 Trials for Ulcerative Colitis / Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02760615Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study